BRISTOL-MYERS SQUIBB COMPANY Long-term Debt, Gross
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Long-term Debt, Gross of $4.50 billion as of 2023-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2026-02-11
- 2023-12-31: Long-term Debt, Gross $4.50B.
- 2022-12-31: Long-term Debt, Gross $6.00B.
- 2022-09-30: Long-term Debt, Gross $6.00B.
- 2022-06-30: Long-term Debt, Gross $6.00B.
| Period end | Long-term Debt, Gross |
|---|---|
| 2023-12-31 | $4.50B 10-K · filed 2026-02-11 |
| 2022-12-31 | $6.00B 10-K · filed 2025-02-12 |
| 2022-09-30 | $6.00B 10-Q · filed 2023-10-26 |
| 2022-06-30 | $6.00B 10-Q · filed 2023-07-27 |
| 2022-03-31 | $6.00B 10-Q · filed 2023-04-27 |
| 2020-12-31 | $7.00B 10-K · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |